Endo Health Solutions ( ENDP) is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. This stock is trading up 1.2% at $33.99 in recent trading. Today's Volume: 2.3 million Average Volume: 1.3 million Volume % Change: 234% Shares of ENDP are moving modestly higher today after the company resolved a long-standing of when its pain medicine Lidoderm goes generic by settling two lawsuits with Watson Pharmaceuticals (WPI). >>22 Biopharma Stocks With Breakout Potential From a technical perspective, ENDP is moving higher here back above its 200-day moving average of $33.68 on above average volume. At last check, ENDP traded a bit above its 50-day moving average of $35.44, after the stock hit an intraday high of $35.60. Traders should now look for long-biased trades if ENDP can trigger a near-term breakout trade. That trade will hit once ENDP takes out its 50-day at $35.60 and then some near-term overheard resistance at $36.30 with high volume. Look for a sustained move or close above those levels with volume that's near or above 1.3 million shares. If we get that action soon, then look for ENDP to make a run at its March high of $39.29. As of the most recently reported quarter, Endo is one of the top holdings of Lee Ainslie's Maverick Capital.